Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03987178
Other study ID # 18-26141
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 27, 2019
Est. completion date March 26, 2020

Study information

Verified date September 2020
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if there are microbiologic alterations of the ocular surface after hot tub exposure. The study will evaluate the number of microbes before and after hot tub use in order to find out whether hot tub exposure has any change on the organisms present on the ocular surface. Participants will be randomized to dunk or not to dunk their head during their time in the hot tub.


Description:

Keratitis is a rare destructive cause of blindness. It typically affects young and healthy individuals, is excruciatingly painful, and difficult to treat. With 60% of cases mis-diagnosed at presentation, acanthamoeba keratitis carries a far worse visual prognosis compared to other cornea infections. Exposure to hot tubs is a widely accepted risk factor. However, the mechanism of infection and prediction of who is at risk is unknown as the vast majority of hot tub users do not become infected.In vivo changes to ocular microbiology after hot tub exposure has never been described.

Changes to ocular microbiology after exposure to hot tubs have not been described. The purpose of this study is to investigate whether there are significant alterations in the microbiology of the conjunctiva after hot tub exposure that may contribute to these changes.

This study will recruit at least 34 subjects, who will be randomized to head submersion versus no head submersion, using at least three different hot tubs. A conjunctival swab, a minimal-risk test performed routinely in the eye clinic, will be performed before and after 15 minutes of hot tub exposure on one eye (randomized) per subject. The swabs will be plated on blood agar (bacterial cultures) and non-nutrient agar (acanthamoeba cultures).

In this prospective study, healthy subjects will be recruited. The study will be Health Insurance Portability and Accountability Act compliant and approved by the Institutional Review Board. All subjects will review and sign an informed consent form.

Each patient will have the conjunctiva of one eye (randomized) cultured. This practically no-risk technique entails touching a polyester-tip swab to the lining of the lower eyelid. Each subject will be randomized to head submersion or no head submersion; this exposure will be masked by the study coordinator. After 15 minutes of hot tub exposure, the subject will have the same eye swabbed for cultures.

Each sample (pre- and post-hot tub) will be randomly assigned a study number. One study coordinator will record and mask data. Water from each tub will be cultured.

The culture plates will be sent to our microbiology facility at UCSF and identification of organisms on the blood agar plates will be performed on our MALDI (mass spectrometry to identify bacteria and fungi). Non-nutrient agar plates will be plated with E. coli overlay and incubated for up to 7 days. The plates will be randomized and the microbiologists will be masked to exposures.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date March 26, 2020
Est. primary completion date March 26, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria:

- greater of 18 years of age

- a willing participant

- healthy

Exclusion criteria:

- pregnancy

- high or low blood pressure

- active diarrhea

- lymphedema

- heart disease

- seizure disorder.

Study Design


Intervention

Behavioral:
Dunk
If randomized to "Dunk," the subject is asked to submerge his or her head in the hot tub at least up to brow level.
Other:
Exposure to Hot Tub
Subjects will be asked to sit in a hot tub for 15 minutes (with an individual timer).

Locations

Country Name City State
United States UCSF San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quantity of organisms Genus-species will be identified for each sample, and quantified with an ordinal scale (0-4). The total of this score will be the quantity for that person-time. The primary analyses will be a Wilcoxon Rank Sum test (Mann-Whitney) between the two arms at the follow-up time point (randomized comparison of dunk vs no-dunk), and a Wilcoxon Signed Rank test between pre-hot-tub and post-hot-tub (longitudinal comparison of all cases).
We estimate that a total of 20 subjects will provide 80% power to detect a 1.25 SD difference in the total quantity score between randomization arms at the post (f/u) time point. We estimate 80% power to detect a .9 SD difference between pre (baseline) and post (f/u) time points in a paired longitudinal analysis.
1 year
Secondary Richness (number of species per sample) of organisms found in the conjunctiva with hot tub use (post-test comparison) The investigators will assess whether organism diversity (richness) changes between arms (post-test comparison) using Simpson's Diversity, expressed in units of effective number (see Jost). We will also assess using Shannon's Diversity. 1 year
Secondary Richness (number of species per sample) of organisms found in the conjunctiva with hot tub use (pre versus post) The investigators will assess whether organism diversity (richness) changes longitudinally (pre vs post-test comparison). 1 year
Secondary Difference in organism profile with hot tub use (pre versus post) The investigators will determine whether the organism profile differs longitudinally (pre vs post-test comparison) using L-2 norm (Euclidean distance) and PERMANOVA. We will also assess using L-1 norm (Manhattan distance) 1 year
Secondary Difference in organism profile with hot tub use (between arms) The investigators will determine whether the organism profile differs between arms (post-test comparison) using L-2 norm (Euclidean distance) and PERMANOVA. We will also assess using L-1 norm (Manhattan distance) 1 year
Secondary Quantity comparing pre-hot tub and post-hot tub swabs We will compare quantity of organisms (amount and type) before and after hot tub use in both arms. We will used a paired t-test for analysis. 1 year
Secondary Specific organisms found in the conjunctiva with hot tub use The investigators will compare specific organisms (Staphylococcus epidermidis, Corynebacterium species) between arms (post-test only) and longitudinally between time points (pre vs post-test) with Bonferroni correction 1 year
See also
  Status Clinical Trial Phase
Completed NCT00407589 - Systemic Pharmacokinetics of BOL-303224-A Phase 1
Terminated NCT03696342 - Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. Phase 3
Withdrawn NCT03698045 - Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers. Phase 1
Completed NCT00357773 - Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis Phase 3
Completed NCT03519516 - Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects Phase 1
Withdrawn NCT01721694 - Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection Phase 3